Click image to enlarge
This study will test the safety and immune response of a new HIV vaccine being developed by the International AIDS Vaccine Initiative.
This study is being conducted at two research sites in the US and we are seeking healthy volunteers to participate at our site here at GW.
After a screening visit to confirm eligibility, the study involves 12 visits to the study clinic. Participants will receive vaccine or placebo at two study visits, about 2 months apart. The study also involves two procedures: leukapheresis and Fine Needle Aspiration (FNA). Leukapheresis is like a blood donation, where participants are hooked up to a machine and some white blood cells are filtered from your blood, while returning the rest to your circulation. FNA is a procedure where a needle, guided by ultrasound, is inserted into your lymph nodes, usually in your armpit, and lymph node cells and some fluid will be collected into the needle. These procedures are both done twice during the study. There are also follow-up visits (with blood draws and brief physical exams) and follow-up phone calls. Study participation is for about 14 months after the first vaccination. Participants are compensated for time/travel for each visit.